Approval · Notice of Compliance 5629 · 1994
KENRAL-VALPROIC: Notice of Compliance 5629
Issued November 9, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5629
- Date
- November 9, 1994
- Company
- Kenral Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anticonvulsant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KENRAL-VALPROIC | 02140047 | Cancelled Post Market |
| KENRAL-VALPROIC | 02140055 | Cancelled Post Market |
| KENRAL-VALPROIC | 02140063 | Cancelled Post Market |
Medicinal ingredients
- VALPROIC ACID 250 MG per CAP
- VALPROIC ACID 500 MG per CAP
- VALPROIC ACID 50 MG per ML